SSEP Fluctuations Due to Dexmedetomidine During Posterior Spine Fusion
Status:
Completed
Trial end date:
2016-06-01
Target enrollment:
Participant gender:
Summary
Intravenous anesthetic agents as far as inhaled agents produce a dose depended increase in
latency and decrease in amplitude of SomatoSensory Evoked Potential (SSEP). Dexmetedomidine,
a highly selective a2 adrenergic agonist, not only minimizes the anesthetic agents but also
the opioids, reducing the analgesic demands. The effect of dexmedetomidine on SSEP has not
been elucidated. We aimed to investigate alterations on somatosensory SSEP in adults during
posterior spinal fusion surgery before and after Dexmedetomidine administration.